SEGALL BRYANT & HAMILL, LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 114 filers reported holding INTERSECT ENT INC in Q3 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEGALL BRYANT & HAMILL, LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q2 2019$385,000
-29.0%
16,935
+0.4%
0.01%
-25.0%
Q1 2019$542,000
+16.8%
16,867
+2.5%
0.01%0.0%
Q4 2018$464,000
-12.5%
16,450
-10.8%
0.01%0.0%
Q3 2018$530,000
-23.5%
18,443
-0.3%
0.01%
-27.3%
Q2 2018$693,00018,5000.01%
Other shareholders
INTERSECT ENT INC shareholders Q3 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,332,773$27,828,0005.75%
First Light Asset Management, LLC 2,036,645$42,525,0002.82%
Altium Capital Management LP 141,856$2,962,0000.82%
PURA VIDA INVESTMENTS, LLC 909,660$18,994,0000.54%
Rock Springs Capital Management LP 1,080,200$22,555,0000.49%
Novo Holdings A/S 508,922$10,626,0000.44%
Davide Leone & Partners Investment Co Ltd. 109,240$2,281,0000.28%
PURA VIDA INVESTMENTS, LLC 256,800$5,362,0000.15%
Bellevue Group AG 617,968$12,903,0000.14%
Gyon Technologies Capital Management, LP 13,318$278,0000.12%
View complete list of INTERSECT ENT INC shareholders